While CEO transitions are seldom smooth, continuity should not be an issue with Herbalife Nutrition given the interim CEO ran the company from 2003 to 2017, Jefferies analyst Akshay Jagdale tells investors in a research note. The analyst also points out that the new CEO is expected to come from company's "strong/long tenured bench." Further, he is encouraged by Herbalife's "strong" Q4 volume performance and reaffirmation of its fiscal 2019 guidance. Jagdale believes Herbalife's business momentum is intact and he keeps a Buy rating on the shares with a $65 price target.